[1]Sehgal V N, Srivastava G, Dogra S, et al.Onychomycosis: an Asian perspective.Skinmed,2010,8(1):37-45[2]Thomas J, Jacobson GA, Narkowicz CK, et al.Toenail onychomycosis: an important global disease burden.J Clin Pharm Ther,2010,35(5):497-519[3]Welsh O, Vera-Cabrera L, Welsh E.Onychomycosis.Clin Dermatol,2010,28(2):151-159[4]Grover C..Khurana A. An update on treatment of onychomycosis. Mycoses,2012,:-[5]Chadeganipour M, Nilipour S, Ahmadi G.Study of onychomycosis in Isfahan, Iran.Mycoses,2010,53(2):153-157[6]Yenisehirli G, Bulut Y, Sezer E, et al.Onychomycosis infections in the Middle Black Sea Region, Turkey.Int J Dermatol,2009,48(9):956-959[7]吴凡,冯姣,孔庆涛,等.中国甲真菌病研究文献计量学分析.中国真菌学杂志,2013,8(2):93-96[8]冯姣,曾梅华,陈军,等.甲癣的病原学研究进展.中国真菌学杂志,2013,8(2):120-123[9]Asz-Sigall D, Lopez-Garcia L, Vega-Memije M E, et al.HLA-DR6 association confers increased resistance to T.rubrum onychomycosis in Mexican Mestizos. Int J Dermatol,2010,49(12):1406-1409[10]Garcia-Romero M T, Granados J, Vega-Memije M E, et al.Analysis of genetic polymorphism of the HLA-B and HLA-DR loci in patients with dermatophytic onychomycosis and in their first-degree relatives.Actas Dermosifiliogr,2012,103(1):59-62[11]Zaitz C, Campbell I, Moraes JR, et al.HLA-associated susceptibility to chronic onychomycosis in Brazilian Ashkenazic Jews.Int J Dermatol,1996,35(9):681-682[12]Svejgaard E, Jakobsen B, Svejgaard A.HLA studies in chronic dermatophytosis caused by Trichophyton rubrum.Acta Derm Venereol,1983,63(3):254-255[13]Ahmed AR, Schreiber P, Aiello J, et al.A preliminary report on the role of some immunologic factors in persistence of chronic tinea pedis.Clin Exp Dermatol,1985,10(1):45-50[14] Tosti A, Hay R, Arenas-Guzman R.Patients at risk of onychomycosis--risk factor identification and active prevention. J Eur Acad Dermatol Venereol,. 2005, 19 Suppl 1: 13-16 |